Two Sigma Securities’s XORTX Therapeutics XRTX Stock Holding History

Two Sigma Securities’s Portfolio XRTX Stock Details XRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,519	Closed	-$7.08K	–	2278
2025 Q4	$7.08K	Buy	+2,519	New	+$8.35K	﹤0.01%	1321
2023 Q2	–	Sell	-59	Closed	-$11.2K	–	3432
2023 Q1	$11.2K	Buy	+59	New	+$14.8K	﹤0.01%	2440

Other funds holding XRTX

KWM

Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Two Sigma Securities's XRTX Position: Q1 2026 in Review

Two Sigma Securities sold out of XORTX Therapeutics (XRTX) in Q1 2026, closing a stake of 2,519 shares — an estimated $7.08K sold.

Two Sigma Securities first reported a position in XRTX in Q1 2023 and held it in 2 quarters. The position peaked at $11.2K in Q1 2023. 3 funds tracked by Wall St. Rank hold XRTX as of Q1 2026.

Two Sigma Securities reported no remaining XORTX Therapeutics position as of Q1 2026 after selling out during the quarter.
Two Sigma Securities sold 2,519 XORTX Therapeutics shares in Q1 2026, an estimated $7.08K.
Two Sigma Securities first reported a position in XORTX Therapeutics in Q1 2023 and held it in 2 quarters.
Two Sigma Securities's XORTX Therapeutics position peaked at $11.2K in Q1 2023.
3 funds tracked by Wall St. Rank held XORTX Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.